Vontobel Holding’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,287
Closed -$540K 1128
2022
Q3
$540K Buy
+11,287
New +$619K 0.01% 691
2022
Q2
Sell
-4,287
Closed -$500K 1121
2022
Q1
$500K Sell
4,287
-1,000
-19% -$117K ﹤0.01% 790
2021
Q4
$803K Buy
5,287
+1,370
+35% +$185K 0.01% 689
2021
Q3
$468K Buy
+3,917
New +$432K ﹤0.01% 816
2021
Q2
Sell
-3,930
Closed -$347K 1183
2021
Q1
$347K Hold
3,930
﹤0.01% 754
2020
Q4
$398K Buy
+3,930
New +$405K ﹤0.01% 724

Other funds holding TNDM

Vontobel Holding's TNDM Position: Q4 2022 in Review

Vontobel Holding sold out of Tandem Diabetes Care (TNDM) in Q4 2022, closing a stake of 11,287 shares — an estimated $540K sold.

Vontobel Holding first reported a position in TNDM in Q4 2020 and held it in 6 quarters. The position peaked at $803K in Q4 2021. 295 funds tracked by Wall St. Rank hold TNDM as of Q4 2022.

  • Vontobel Holding reported no remaining Tandem Diabetes Care position as of Q4 2022 after selling out during the quarter.
  • Vontobel Holding sold 11,287 Tandem Diabetes Care shares in Q4 2022, an estimated $540K.
  • Vontobel Holding first reported a position in Tandem Diabetes Care in Q4 2020 and held it in 6 quarters.
  • Vontobel Holding's Tandem Diabetes Care position peaked at $803K in Q4 2021.
  • 295 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2022.

Based on Vontobel Holding's 13F filing for Q4 2022, filed 14 Feb 2023.